UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Auto investing in Dividend Aristocrats ETF helps maintain discipline and harness compounding. Here's why this approach supports steady, long-term growth.
21,043 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
The U.S. confirms the death of a service member amid renewed clashes in the Middle East. Families and investors face ...
Circle led a broad crypto-stock rally on Monday, with shares up near 10% as Bitcoin rallied and stablecoin momentum b...
As AMD gears up for its July 22 AI event, traders are weighing the risk and reward. This article outlines why the set...
Ferrari's latest results underscore its asset-like status, delivering strong cash flow while preparing for an electri...
AD Mortgage has sent a policy letter to the FHFA raising concerns about proposed condo financing criteria changes for...
Market observers say political shocks, energy costs, and shifting policy paths are creating a fragile backdrop for ho...
When a founder sells a portion of stock, investors often wonder if it signals trouble or opportunity. This deep dive ...
Cruise stocks are among the S&P 500’s biggest decliners as Middle East tensions and higher fuel costs bite into deman...
Lauren Sánchez Bezos is fueling a $34 million Bezos Earth Fund push to reinvent fabrics—from bacteria-grown fibers to...
As layoffs linger in tech and startups recalibrate, candidates confront the toughest interview question: why were you...
A massive compute deal rumor could redraw the AI cloud map. This article explains what the potential billion compute ...